Pacific Biosciences of California, Inc. (PACB) Tops Q1 EPS by 1c

Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q1 EPS of ($0.27), $0.01 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $11.4 million versus the consensus estimate of $11.39 thousand.

For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
• Diana Shipping withdraws bid to acquire Genco Shipping